Conference
A phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC): an interim analysis
Authors
Juergens R; Vendetti F; Coleman B; Sebree R; Belinsky S; Rudek M; Brock M; Herman J; Baylin S; Rudin C
Volume
4
Pagination
pp. S306-S307
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
September 1, 2009
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
Issue
9
ISSN
1556-0864